MINORS Items | Breslow et al. | Su et al. | Fuchs et al. | Ehrlich et al. | Aronson et al. | Berger et al. | Liné et al. | Varan et al. | Jain et al. | |
---|---|---|---|---|---|---|---|---|---|---|
Clearly stated aim | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | |
Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Prospective collection of data | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | |
Endpoints appropriate to aim of study | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | |
Unbiased assessment of the study endpoint | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | |
Follow-up period appropriate to aim of study | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Loss to follow up less than 5% | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | |
Prospective calculation of the study size | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
An adequate control group | 1 | - | 1 | 1 | 0 | 0 | 1 | 1 | - | |
Contemporary groups | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | - | |
Baseline equivalence of groups | 1 | - | 1 | 0 | 0 | 0 | 0 | 1 | - | |
Adequate statistical analyses | 1 | - | 1 | 1 | 0 | 1 | 1 | 1 | - | |
Total | 17/24 | 9/16 | 18/24 | 16/24 | 13/24 | 16/24 | 18/24 | 15/24 | 10/16 |